| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | Rothenberg Mace | director | Award | 5,550 | $30.14 | $167K |
| 2026-05-13 | WOODHOUSE DAVID J | director | Award | 5,550 | $30.14 | $167K |
| 2026-05-13 | Haak-Frendscho Mary | director | Award | 5,550 | $30.14 | $167K |
| 2026-05-13 | CHAI CHRISTOPHER Y | director | Award | 5,550 | $30.14 | $167K |
| 2026-05-13 | BJERKHOLT ERIC | director | Award | 5,550 | $30.14 | $167K |
| 2026-05-13 | Berkenblit Anna | director | Award | 5,550 | $30.14 | $167K |
| 2026-05-04 | Parker Craig C | director, officer | Sale | 4,524 | $33.33 | $151K |
| 2026-05-04 | Williams Charles O | officer | Sale | 2,036 | $33.33 | $68K |
| 2026-05-04 | Li Yang | officer | Sale | 1,584 | $33.33 | $53K |
| 2026-05-01 | Li Yang | officer | Option exercise | 4,375 | — | — |
| 2026-05-01 | Williams Charles O | officer | Option exercise | 5,625 | — | — |
| 2026-05-01 | Parker Craig C | director, officer | Option exercise | 12,500 | — | — |
| 2026-03-31 | Li Yang | officer | Gift | 1,666 | — | — |
| 2026-03-24 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 53,329 | $24.69 | $1.32M |
| 2026-03-23 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 7,612 | $24.90 | $190K |
| 2026-03-23 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 7,611 | $24.90 | $190K |
| 2026-03-16 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 595 | $24.99 | $15K |
| 2026-03-13 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 17,717 | $24.88 | $441K |
| 2026-03-13 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 17,716 | $24.88 | $441K |
| 2026-03-12 | TCG Crossover GP II, LLC | 10%+ owner | Buy | 6,187 | $24.99 | $155K |
| 2026-02-17 | Li Yang | officer | Award | 100,950 | $24.53 | $2.48M |
| 2026-02-17 | Williams Charles O | officer | Award | 102,900 | $24.53 | $2.52M |
| 2026-02-17 | Parker Craig C | director, officer | Award | 242,200 | $24.53 | $5.94M |
| 2026-02-17 | Parker Craig C | director, officer | Award | 242,200 | — | — |
| 2026-02-17 | Williams Charles O | officer | Award | 102,900 | — | — |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-05-18 | SCHEDULE 13D/A | COLUMN GROUP III GP, LP | — | 2,962,544 | view → |
| 2026-01-22 | SCHEDULE | COLUMN GROUP III GP, LP | 35.10% | 3,824,612 | view → |
| 2024-04-08 | SC | COLUMN GROUP III GP, LP | — | — | view → |
| 2021-09-29 | SC | Consonance Capital Management LP | — | — | view → |
| 2021-08-18 | SC | Consonance Capital Management LP | — | — | view → |
| 2021-04-27 | SC | Consonance Capital Management LP | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-07 | SCHEDULE 13G | Sagimet Biosciences Inc. | — | — | view → |
| 2026-09-02 | SCHEDULE 13G | JATT III Acquisition Corp | — | — | view → |
| 2026-08-17 | SCHEDULE 13G | InflaRx N.V. | — | — | view → |
| 2026-07-20 | SCHEDULE 13G | Research Alliance Corp IV | — | — | view → |
| 2026-06-18 | SCHEDULE 13G | Avalo Therapeutics, Inc. AVTX | — | — | view → |
| 2026-06-03 | SCHEDULE 13G | EyePoint, Inc. EYPT | — | — | view → |
| 2026-06-02 | SCHEDULE 13G | Editas Medicine, Inc. EDIT | — | — | view → |
| 2026-05-28 | SCHEDULE 13G | Research Alliance Corp III RACC | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →